SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-04-09 11:19
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-24,602 vol 		41,705
Filed 2023-04-09 11:17
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-1,552 vol 		66,307
Filed 2023-04-09 11:16
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-6,065 vol 		67,859
Filed 2023-04-09 11:13
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$90,289
+24,602 vol
$3.67 each 		84,036
Filed 2023-04-09 11:11
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$5,773
+1,552 vol
$3.72 each 		59,434
Filed 2023-04-09 11:10
Tx date 2023-03-29 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$22,743
+6,065 vol
$3.75 each 		57,882
Filed 2023-03-23 17:11
Tx date 2023-03-16 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+3,928 vol 		73,924
Filed 2023-03-23 15:19
Tx date 2023-03-16 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$10,668
+2,845 vol
$3.75 each 		197,934
Filed 2022-04-04 19:19
Tx date 2022-04-01 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-1,552 vol 		69,996
Filed 2022-04-04 19:19
Tx date 2022-04-01 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-24,603 vol 		71,548
Filed 2022-04-04 19:18
Tx date 2022-04-01 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$3,243
+1,552 vol
$2.09 each 		51,817
Filed 2022-04-04 19:17
Tx date 2022-04-01 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$55,356
+24,603 vol
$2.25 each 		50,265
Filed 2022-03-30 14:40
Tx date 2022-03-17 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+24,260 vol 		96,151
Filed 2022-03-30 14:39
Tx date 2022-03-17 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$103,452
+47,674 vol
$2.17 each 		195,089
Filed 2021-06-04 11:52
Tx date 2021-03-21 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-24,603 vol 		71,891
Filed 2021-05-26 10:23
Tx date 2021-03-21 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$25,833
+24,603 vol
$1.05 each 		25,662
Filed 2020-05-29 16:46
Tx date 2020-05-26 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,059 vol 		1,059
Filed 2020-05-29 16:46
Tx date 2018-06-04 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-29 16:45
Tx date 2020-05-26 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
-1,916 vol 		96,494
Filed 2020-04-12 10:28
Tx date 2020-04-08 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+90,747 vol 		98,410
Filed 2020-04-12 10:27
Tx date 2020-04-08 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$46,669
+64,819 vol
$0.72 each 		147,415
Filed 2019-04-23 22:27
Tx date 2019-04-11 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+7,663 vol 		7,663
Filed 2019-04-23 18:48
Tx date 2019-04-11 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options
+7,663 vol 		7,663
Filed 2019-04-23 18:48
Tx date 2019-04-11 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options
+7,663 vol
Filed 2019-04-23 18:48
Tx date 2018-06-04 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-23 18:47
Tx date 2019-04-11 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$39,745
+26,855 vol
$1.48 each 		82,596
Filed 2018-08-14
Tx date 2018-06-04 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-14
Tx date 2018-08-14 		$CPH
Cipher Pharmaceuticals Inc. 		Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$169,452
+55,741 vol
$3.04 each 		55,741